Search research articles
Contact Us
Filters
Showing results (291-300 of 342) with videos related to
Page
of 35
Sort By:
Sexually Transmitted Infections
|
February 9, 2026
Cross-sectional evaluation of a lateral flow assay for point-of-care detection of <i>Neisseria gonorrhoeae</i> in asymptomatic individuals at primary healthcare facilities in South Africa
Remco P H Peters, Jeffrey D Klausner, Laura T Mazzola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations
J A Lawrence, P C Adamson, R Caruso, et al.
Plos One
|
November 26, 2015
Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group
Yimei Li, Matt Hall, Brian T Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2008
A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors
Elizabeth Fox, John M Maris, Brigitte C Widemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study
Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
Pediatric Blood & Cancer
|
September 27, 2014
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium
Stephan D Voss, Julia Glade-Bender, Sheri L Spunt, et al.
The Journal of Infectious Diseases
|
February 12, 2025
High prevalence of ceftriaxone-resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024
Jolein Gyonne Elise Laumen, Vu N Hieu, Pham H Nhung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2012
Recommendations for the return of research results to study participants and guardians: a report from the Children's Oncology Group
Conrad V Fernandez, Kathleen Ruccione, Robert J Wells, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2010
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report
Maryam Fouladi, Julie R Park, Clinton F Stewart, et al.
Page
of 35
Search research articles
Search
Showing results (291-300 of 342) with videos related to
Sort By:
Page
of 35
Sexually Transmitted Infections
|
February 9, 2026
Cross-sectional evaluation of a lateral flow assay for point-of-care detection of <i>Neisseria gonorrhoeae</i> in asymptomatic individuals at primary healthcare facilities in South Africa
Remco P H Peters, Jeffrey D Klausner, Laura T Mazzola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations
J A Lawrence, P C Adamson, R Caruso, et al.
Plos One
|
November 26, 2015
Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group
Yimei Li, Matt Hall, Brian T Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2008
A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors
Elizabeth Fox, John M Maris, Brigitte C Widemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study
Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
Pediatric Blood & Cancer
|
September 27, 2014
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium
Stephan D Voss, Julia Glade-Bender, Sheri L Spunt, et al.
The Journal of Infectious Diseases
|
February 12, 2025
High prevalence of ceftriaxone-resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024
Jolein Gyonne Elise Laumen, Vu N Hieu, Pham H Nhung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Jennifer H Foster, Stephan D Voss, David C Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2012
Recommendations for the return of research results to study participants and guardians: a report from the Children's Oncology Group
Conrad V Fernandez, Kathleen Ruccione, Robert J Wells, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 8, 2010
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report
Maryam Fouladi, Julie R Park, Clinton F Stewart, et al.
Page
of 35